Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

BACKGROUND: Waning of vaccine protection against coronavirus disease 2019 (Covid-19) and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have led to expedited efforts to scale up booster vaccination. Protection conferred by boos...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Raddad, Laith J., Chemaitelly, Hiam, Ayoub, Houssein H., AlMukdad, Sawsan, Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Tang, Patrick, Hasan, Mohammad R., Coyle, Peter, Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar H., Latif, Ali N., Shaik, Riyazuddin M., Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed Ghaith, Butt, Adeel A., Al-Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929389/
https://www.ncbi.nlm.nih.gov/pubmed/35263534
http://dx.doi.org/10.1056/NEJMoa2200797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929389/
https://www.ncbi.nlm.nih.gov/pubmed/35263534
http://dx.doi.org/10.1056/NEJMoa2200797

Ejemplares similares